Matches in Wikidata for { <http://www.wikidata.org/entity/Q95330962> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q95330962 description "article scientifique publié en 2020" @default.
- Q95330962 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95330962 description "scientific article published on 20 May 2020" @default.
- Q95330962 description "wetenschappelijk artikel" @default.
- Q95330962 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95330962 name "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 name "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 type Item @default.
- Q95330962 label "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 label "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 prefLabel "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 prefLabel "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 P1433 Q95330962-C09508C6-C99C-4366-95EC-DD3B96838AA9 @default.
- Q95330962 P1476 Q95330962-9EC34ADB-E6F0-4DA2-B9A7-59715F9F5A87 @default.
- Q95330962 P2093 Q95330962-2FA2F5CC-8406-47FA-BD4F-554DB79915E9 @default.
- Q95330962 P2093 Q95330962-5E433BE4-DB2B-4C1E-A709-B92D8925BDE0 @default.
- Q95330962 P2093 Q95330962-84212E8F-A6C2-4F9B-A102-669E2B62521F @default.
- Q95330962 P2093 Q95330962-FDA6DBCF-C856-49E5-9DC8-8381F5F1C1E8 @default.
- Q95330962 P31 Q95330962-9F221538-2DEE-49CF-AC00-DB644F49EBDD @default.
- Q95330962 P356 Q95330962-9C84F787-C37C-4058-8C35-19FBB1CC1C7B @default.
- Q95330962 P50 Q95330962-770E9F9D-2004-448B-9ADB-4656C47E8C26 @default.
- Q95330962 P577 Q95330962-F7325636-967D-4061-86A2-62F96FC8EE46 @default.
- Q95330962 P698 Q95330962-0EAD1F07-5854-48C5-81D8-8158BDB37F7F @default.
- Q95330962 P921 Q95330962-CFD11366-99C0-4A3C-AAC6-319992EAB7EB @default.
- Q95330962 P356 17425247.2020.1772749 @default.
- Q95330962 P698 32434390 @default.
- Q95330962 P1433 Q5421203 @default.
- Q95330962 P1476 "Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin" @default.
- Q95330962 P2093 "Mahdi Hatamipour" @default.
- Q95330962 P2093 "Mahmoud R Jaafari" @default.
- Q95330962 P2093 "Seyed Mohammad Gheibi Hayat" @default.
- Q95330962 P2093 "Tannaz Jamialahmadi" @default.
- Q95330962 P31 Q13442814 @default.
- Q95330962 P356 "10.1080/17425247.2020.1772749" @default.
- Q95330962 P50 Q87546331 @default.
- Q95330962 P577 "2020-05-20T00:00:00Z" @default.
- Q95330962 P698 "32434390" @default.
- Q95330962 P921 Q18936 @default.